LineaRx signs agreement with TYME Technologies for functional invasive circulating tumour cell assay services in pancreatic cancer trial
The potential value of the agreement is the largest contract to-date for LineaRx, and the largest in the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Nov 19
The potential value of the agreement is the largest contract to-date for LineaRx, and the largest in the…
29 Nov 19
Genetron S5 semiconductor-based NGS system will help detect changes in pH value in nucleotides
29 Nov 19
The approval will let Qiagen and DiaSorin offer streamlined laboratory automation for latent TB screening
28 Nov 19
Thoroughbred Diagnostic Labs partnered with Wheeler Financial from Pitney Bowes to secure the capital it needed to invest…
28 Nov 19
The Visium Spatial Gene Expression Solution builds on the foundation of Spatial Transcriptomics’ earlier product offering, providing researchers…
27 Nov 19
The programme is based on Edison, GE Healthcare’s secure intelligence platform
The prospective, multi-center clinical study is the first in the United States to formally validate the performance of…
As an independent, full-service clinical and anatomical pathology laboratory dedicated to providing diagnostic excellence, Alliance Laboratories provides over…
26 Nov 19
The partnership will develop companion diagnostics for Wave’s investigational allele-selective therapeutic programmes targeting Huntington’s disease
26 Nov 19
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer,